eMedonline®/ NIH Drug Compliance Study Results to be Presented
Summary
“eMedonline™ integrates most, if not all, of the key features required for behavior change, which up until now, have been addressed separately by numerous other approaches,” said David Lindeman, M.D., Director of the Center for Technology and Aging.Leap of Faith Technologies, Inc. is a privately-held company pioneering real-time ehealth, disease management solutions for eliciting behavior change and providing timely clinical information.### Crystal Lake, IL, January 30, 2010 --( PR.com )-- Leap of Faith Technologies, Inc., today announced that Barbara A. Rapchak, Founder and CEO, will present data from a National Cancer Institute funded clinical study confirming the effectiveness of the company’s eMedonline™ wireless platform technology to achieve higher levels of medication compliance among patients taking one to 10 prescription medications daily.Three out of four Americans do not take their medicine as directed, a dilemma which leads to additional doctor visits, hospitalizations, early admission to assisted-care facilities, and other treatments.Leap of Faith’s eMedonline® wireless platform technology integrates cell phones, radio frequency identification (RFID), and health and behavioral informatics to optimize medication compliance, track medication use, and extend patient care to the ambulatory setting.“eMedonline™ integrates most, if not all, of the key features required for behavior change, which up until now, have been addressed separately by numerous other approaches,” said David Lindeman, M.D., Director of the Center for Technology and Aging.